NCT05355701 2026-02-03
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Pfizer
Phase 1 Recruiting
Pfizer
Shanghai Junshi Bioscience Co., Ltd.
UNC Lineberger Comprehensive Cancer Center